Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), bought 10,000 shares at $5.39 ($27K) on 2008-03-10, disclosed to the SEC on 2008-03-12.
Open-market purchase of $27k ARRY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,000 | $0 | 0.0% |
| 2 | $5.38 | 2,000 | $11K | 40.0% |
| 3 | $5.39 | 3,000 | $16K | 60.0% |
| Total | $2.69 avg | 10,000 | $27K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |